Pediatrics_Bio
ProQR Receives Rare Pediatric Disease Designation from FDA for QR421a: LEIDEN Netherlands & CAMBRIDGE Mass. Jan. 30 2020 GLOBE NEWSWIRE ProQR Therapeutics N.V. NasdaqPRQR a company dedicated to changing lives through the creation of transformative… https://t.co/dGtJVgXG8p
— Pediatrics News (@Pediatrics_Bio) January 30, 2020
Posts
0 Comments